Adaptation of enterovirus to vero cells and vaccine formulations thereof
AssigneeBharat Biotech International Limited
InventorsAmit Raychoudhuri, Krishna Murthy Ella
Life of this patent
Estimating the term…
Abstract
Provided is an Enterovirus D68 adapted to propagate to high titers in Vero cells and method of adaptation thereof. Also provided is a suitable vaccine composition including inactivated Enterovirus D68 antigen.
Claims11
An Enterovirus D68 adapted to propagate to high titers in Vero cells encoded by a cDNA molecule having the nucleotide sequence of SEQ ID NO:
- 1.
A nucleotide sequence encoding the Vero cell adapted Enterovirus D68 polyprotein disclosed in SEQ ID NO:
- 2.
An amino acid sequence of Vero cell adapted Enterovirus D68 polyprotein disclosed in SEQ ID NO:
- 3.
A method of adapting Enterovirus D68 to propagate in Vero cells to high titer comprising:
- (f) infecting the virus by adsorbing for about 60-120 minutes at 32-35° C.;
- (g) propagating the virus after addition of the maintenance media at 32-35° C.;
- (h) diluting the virus stock obtained from each passage at 1:3 to 1:10 dilution to infect the next batches of Vero cells for initial passages of the virus at 32-35° C.;
- (i) diluting the virus at 1:20-1:500 dilution to infect the Vero cells during later/subsequent passages at 32-35° C.;
- and
- (j) harvesting the virus during every passage when 90% or more cytopathic effect has been achieved or within 6 days of infection.
A method of inactivating Enterovirus D68 containing cDNA encoded from SEQ ID NO:
- 1 for immunization comprising:
- (a) sterile filtration of the harvested Enterovirus D68 virus;
- (b) removal of the host nucleic acid using nuclease treatment and concentrated by tangential flow filtration using 100 kDa filter;
- (c) inactivation using 1/2000- 1/4000 formalin for up to 3 weeks at temperature varying from 25-37° C. or with BPL at 4-25° C. for up to 120 hours or with 0.005% to 3% hydrogen peroxide at 25±5° C. for up to 6 hours;
- and
- (d) purification of inactivated antigen or purification before inactivation of the viral antigen by gel filtration using Sepharose CL-4B followed by anion exchange chromatography using DEAE resins or by double steps/two rounds of size exclusion chromatography or by cellufine sulphate followed by anion exchange chromatography or by mixed mode resins like CHT Type II (Biorad) alone or in combination with the other resin or combination of chromatography methods.
An amino acid sequence belonging to Enterovirus D68 having amino acid in the polyprotein selected from L341, G647, K699, K719, N1355, S1406, Q2110 or combination thereof.
An immunogenic composition comprising inactivated Enterovirus D68 virus antigen in a physiological acceptable vehicle, wherein the Enterovirus D68 is having amino acid in the polyprotein selected from L341, G647, K699, K719, N1355, S1406, Q2110 or combination thereof.
Dependencies are inferred from the claim text.